We expanded these observations, and found that the expression of CXCL13 was elevated in the tumor tissues from 63/70 (90%) HPR patients (Figure 1B) and 71/131 (54.2%) CR patients (Table 1) compared with their normal controls. The gene discussed is CXCL13; the disease is neoplasm.